Aptar Pharma has partnered with Shanghai Sine Promod Pharmaceutical to develop and launch its new budesonide dry powder inhaler (DPI), which features Aptar Pharma’s user-friendly and cost-effective ...

IRVINE, CA--(Marketwired - Feb 24, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce updates on the ...

Asthma and COPD are major obstructive diseases characterized by chronic obstruction of lung airflow that interferes with normal breathing. A Dry Powder Inhaler (DPI) is considered the most preferred ...

Choice of carrier can have a significant impact on the capsule filling process as well as the performance of the DPI formulation. The use of capsules loaded into a dry powder inhaler (DPI) to deliver ...

Patients who switched from a pressurized metered dose inhaler (pMDIs) to a dry powder inhaler (DPI) halved their carbon footprints while still maintaining good asthma control, a post-hoc analysis of ...

Researchers in the United Kingdom compared the potential impact on carbon footprint and asthma symptom control of switching maintenance therapy to a dry powder inhaler vs continuing with a metered ...

Emerging pharmaceutical firm Adamis Pharmaceuticals Corporation (ADMP) has recently acquired the exclusive license to 3M Company's (MMM) Taper Dry Powder Inhaler (:DPI) technology. With an additional ...

Innohaler, a DPI device, to make life easier for asthma and chronic obstructive pulmonary disease (COPD) has been developed and successfully registered. Innohaler, a dry powder inhaler (DPI) device, ...

Reducing the use of metered-dose inhalers for asthma could shrink the carbon footprint while achieving cost savings if less expensive brands of dry powder inhalers are used, according to new research ...

Wilmington, DE – February 24, 2007 – New data demonstrated the maintenance combination asthma therapy, SYMBICORT® (budesonide/formoterol fumarate dehydrate ...